Who
Anthony S. Marucci
President & CEO
Company insider
Files Form 4 as: President & CEO, Celldex Therapeutics.
In numbers
- Trades disclosed
- 58
- Buys
- 6
- Sells
- 1
- Bought
- $580K
- Sold
- $4.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Jan 2009
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —375,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —375,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 11 Nov 2024filed 12 Nov 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Bought | $308K11,500 at $26.82 | filing |
| 13 Jun 2024filed 17 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 15 Aug 2022filed 17 Aug 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —75,000 at $0.00 | filing |
| 15 Aug 2022filed 17 Aug 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —45,000 at $0.00 | filing |
| 15 Aug 2022filed 17 Aug 2022 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $209K75,000 at $2.78 | filing |
| 15 Aug 2022filed 17 Aug 2022 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $406K45,000 at $9.02 | filing |
| 15 Aug 2022filed 17 Aug 2022 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $4.5M120,000 at $37.66 | filing |
| 16 Jun 2022filed 17 Jun 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 5 Aug 2021filed 9 Aug 2021 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $149K3,537 at $42.00 | filing |
| 5 Aug 2021filed 9 Aug 2021 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —3,537 at $0.00 | filing |
| 17 Jun 2021filed 21 Jun 2021 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —224,000 at $0.00 | filing |
| 18 Jun 2020filed 19 Jun 2020 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —245,000 at $0.00 | filing |
| 9 Jun 2020filed 10 Jun 2020 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Bought | $46K15,000 at $3.06 | filing |
| 19 Jun 2019filed 20 Jun 2019 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 13 Jun 2018filed 15 Jun 2018 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —1,075,000 at $0.00 | filing |
| 15 Jun 2017filed 16 Jun 2017 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —475,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.